← Evidence map

ArticleClinical drug investigation2025

Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom".

Pablo E Bretos-Azcona et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom". | OpenQuestion